“If your nasal polyps get to a phase in which you have a very large and significant polyp load, it’s very hard to get them to go away,” she says. Treatment and Medication Options for Nasal ...

The first-line treatment options for nasal polyps are typically medications, such as: If your symptoms persist or get worse ...

Nasal sinusitis, commonly called a sinus infection, is a condition characterised by inflammation or swelling of the tissue ...

In CRS with and without nasal polyps, medical treatment, including nasal and oral corticosteroids, is the first therapeutic option. The treatment of CRS still remains an unmet need ...

Sanofi and Regeneron’s Dupixent has had the US market for the treatment of chronic rhinosinusitis with nasal polyps (CRSwNP) mainly to itself since June 2019, but GlaxoSmithKline’s Nucala is ...

AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...

but according to Amgen findings showed treatment with tezepelumab statistically significantly and clinically meaningfully reduced the size of nasal polyps and nasal congestion compared with placebo.

When sinusitis does not respond to treatment, your doctor may recommend surgery to remove a polyp or nasal tissue.

(Alliance News) - AstraZeneca PLC on Friday said it received positive results from a trial of Tezspire as a treatment for chronic rhinosinusitis with nasal polyps. Chronic rhinosinusitis is a ...

Patients with CRSwNP have a high burden of SCS use and associated health care costs, especially when they have comorbid asthma.

AstraZeneca and Amgen have released topline data from a Phase III trial of its inflammatory therapy, Tezspire (tezepelumab) in patients with chronic rhinosinusitis with nasal polyps (CRSwNP).

Participants in the trial were symptomatic despite treatment with standard of care (intranasal corticosteroids [INCS]). Chronic rhinosinusitis with nasal polyps is a condition that can cause ...